Nina Levenda, MD
Obstetrics & Gynecology · Fort Wayne, INNPI 1972685543
Payments from drug & device makers
Across 89 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$547
- Hologic Sales And Service, LLC$190
- Astellas Pharma US Inc$92
- Coopersurgical, Inc.$90
- Mayne Pharma Commercial LLC$59
- Bayer$53
- plus $486 from 18 others
What the payments were for
- Food & beverage$1,516100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $547 |
| Hologic Sales And Service, LLC | 6 | $190 |
| Astellas Pharma US Inc | 5 | $92 |
| Coopersurgical, Inc. | 1 | $90 |
| Mayne Pharma Commercial LLC | 5 | $59 |
| Bayer | 4 | $53 |
| Exeltis, USA Inc. | 3 | $44 |
| Pfizer | 3 | $43 |
| Amgen | 3 | $41 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Myovant Sciences Inc. | 2 | $38 |
| Avion Pharmaceuticals | 3 | $38 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Baxter Healthcare | 1 | $32 |
| Organon | 2 | $22 |
| Meditrina | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Millicent US Inc | 1 | $14 |
| Merck | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $12 |
| Novo Nordisk | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acessa$116
How this compares
$1,516 in reported general payments places this provider in the 65th percentile of 743 obstetrics & gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 24 | $815 |
| Medroxyprogesterone Acetate | 19 | $721 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $199 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $106 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fort Wayne
- Tracy BellavanceFort Wayne$337K
- Keith DavisFort Wayne$153K
- Ashley ScottFort Wayne$124K
- Francis EsguerraFort Wayne$11K
- Steven TannerFort Wayne$8K
- Caitlin BernardIndianapolis$352K
- Arundathi PrasadIndianapolis$343K
- Constantine ScordalakesNewburgh$270K
- Todd RumseyAngola$245K
- Chemen NealIndianapolis$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.